ACE2 and infection: Interfering with terminal glycosylation of ACE2 may negatively influence the virus-receptor binding and abrogate infection, with further ramifications by the elevation of TGN/vesicular pH, resulting in the inhibition of infection and spread of SARS CoV-1 at clinically admissible concentrations.